Donépézil (Aricept®)

1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Donepezil is one of the reversible acetylcholinesterase inhibitors which has been licensed in France since 1997 for use in patients with mild to moderate Alzheimer's disease. There is an abundant body of recently published on this molecule. This article is a review of the main papers relevant to donepezil. © 2008 Elsevier Masson SAS. All rights reserved.

Cite

CITATION STYLE

APA

Trivalle, C. (2008). Donépézil (Aricept®). NPG Neurologie - Psychiatrie - Geriatrie, 8(44), 19–23. https://doi.org/10.1016/j.npg.2008.02.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free